GEODE CAPITAL MANAGEMENT, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 16 filers reported holding LEAP THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$210,348
+75564.7%
618,6730.0%0.00%
Q4 2022$278
-99.9%
618,673
+1.6%
0.00%
Q3 2022$535,000
-23.6%
608,7650.0%0.00%
Q2 2022$700,000
-34.3%
608,7650.0%0.00%
Q1 2022$1,065,000
-41.9%
608,765
+7.7%
0.00%
Q4 2021$1,832,000
+16.6%
565,483
+44.3%
0.00%
Q3 2021$1,571,000
+161.0%
391,893
+6.7%
0.00%
Q2 2021$602,000
-9.2%
367,321
+5.1%
0.00%
Q1 2021$663,000
-1.3%
349,441
+16.8%
0.00%
Q4 2020$672,000
+101.2%
299,051
+76.8%
0.00%
Q3 2020$334,000
+9.2%
169,162
+15.5%
0.00%
Q2 2020$306,000
+29.7%
146,513
-1.9%
0.00%
Q1 2020$236,000
-35.9%
149,378
-54.6%
0.00%
Q4 2019$368,000
+91.7%
328,986
+100.0%
0.00%
Q3 2019$192,000
-34.7%
164,4930.0%0.00%
Q2 2019$294,000
+47.0%
164,493
+53.7%
0.00%
Q1 2019$200,000
+31.6%
107,013
+40.4%
0.00%
Q4 2018$152,000
-48.6%
76,234
+100.0%
0.00%
Q3 2018$296,000
-4.5%
38,117
+10.4%
0.00%
Q2 2018$310,00034,5170.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders